Research Article
TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients
Table 4
Correlations of the percentage of CD14+ TREM-1+ blood cells with IL-6/IL-10 ratio and plasma level of IL-10.
| % of CD14+TREM-1+ cells | | | | 95% CI |
| G. II | IL-6/IL-10 | Spearman | 0.422 | | | 0.092 | -0.090 to 0.757 | IL-10 | Spearman | -0.678 | | | 0.002 | -0.873 to -0.295 | G. III | IL-6/IL-10 | Spearman | | | | Non sg. | | IL-10 | Spearman | | | | Non sg. | | G. IV | IL-6/IL-10 | Spearman | 0.535 | | | 0.033 | 0.038 to 0.820 | IL-10 | Spearman | -0.740 | | | 0.0002 | -0.894 to -0.430 | All gliomas | IL-6/IL-10 | Spearman | 0.427 | | | 0.007 | 0.119 to 0.660 | IL-10 | Spearman | -0.623 | | | <0.0001 | -0.779 to -0.396 |
|
|
G: grade; IL: interleukin; Non sg: nonsignificant.
|